Renal Cancer - Results from #6300

Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modifications - Abstract April 13, 2015

Renal leiomyoma: A contemporary multi-institution study of an infrequent and frequently misclassified neoplasm - Abstract April 11, 2015

Health-related quality of life, personality and choice of coping are related in renal cell carcinoma patients - Abstract April 11, 2015

Sunitinib-induced severe toxicities in a Japanese patient with the ABCG2 421 AA genotype - Abstract April 11, 2015

Comparison of perioperative outcomes of robotic versus laparoscopic partial nephrectomy for complex renal tumors (RENAL nephrometry score of 7 or higher) - Abstract April 9, 2015

Unilateral synchronous occurrence of renal pelvic urothelial carcinoma and renal cell carcinoma: Report of two cases - Abstract April 9, 2015

Impact of sequential targeted therapy on progression-free survival in metastatic renal cell carcinoma - Abstract April 9, 2015

Laparoscopic nephrectomy, ex vivo partial nephrectomy, and autotransplantation for the treatment of complex renal masses - Abstract April 8, 2015

Renal sinus fat invasion and tumoral thrombosis of the inferior vena cava-renal vein: Only confined to renal cell carcinoma - Abstract April 8, 2015

Imaging spectrum of renal oncocytomas: A pictorial review with pathologic correlation - Abstract April 8, 2015

Sunitinib-induced complete response in metastatic renal cancer expressing neuroendocrine markers: A new predictive factor? - Abstract April 8, 2015

Association of drug exposure with toxicity and clinical response in metastatic renal cell carcinoma patients receiving an attenuated dosing regimen of sunitinib - Abstract April 7, 2015

Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma - Abstract April 7, 2015

Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: A multi-institutional analysis - Abstract April 7, 2015

First-line and sequential use of pazopanib followed by mammalian target of rapamycin inhibitor therapy among patients with advanced renal cell carcinoma in a US community oncology setting - Abstract April 7, 2015

Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: A systematic review and meta-analysis of real-world observational studies - Abstract April 7, 2015

Survival after renal cell carcinoma metastasis to the thyroid: Single center experience and systematic review of the literature - Abstract April 7, 2015

De novo renal cell carcinoma in an allograft kidney treated with nephron-sparing surgery: A case report - Abstract April 3, 2015

Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey - Abstract April 3, 2015

Prognostic factors for overall survival with targeted therapy in Chinese patients with metastatic renal cell carcinoma - Abstract April 3, 2015

Page 316 of 456